Kyverna Therapeutics (KYTX) Current Leases (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Current Leases of $1.8 million for Q1 2026, down 51.83% on a QoQ basis from $3.7 million in Q4 2025, and up 247.93% year-over-year from $507000.0 in Q1 2025.
Kyverna Therapeutics (KYTX) Current Leases (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- Quarterly Current Leases rose 247.93% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 247.93% YoY) and the FY2025 annual result came in at $3.7 million, up 15.85% from the prior year.
- Current Leases was $1.8 million for Q1 2026 at Kyverna Therapeutics, down from $3.7 million in the prior quarter.
- Across five years, Current Leases topped out at $3.7 million in Q4 2025 and bottomed at $190000.0 in Q3 2025.
- A 4-year average of $1.4 million and a median of $991000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases tumbled 79.59% — and 2026, when it jumped 247.93%.
- Kyverna Therapeutics' Current Leases stood at $2.0 million in 2023, then jumped by 60.95% to $3.2 million in 2024, then advanced by 15.85% to $3.7 million in 2025, then slumped by 51.83% to $1.8 million in 2026.
- Business Quant data shows KYTX's Current Leases at $1.8 million in Q1 2026, $3.7 million in Q4 2025, and $190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 190,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 931,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 979,000.00 |
| Dec 31, 2023 | 1.96 Mn |